EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review

Mojtaba Ansari iD, Mostafa Rezaei Tavirani iD

Iranian Journal of Pharmaceutical Research · 2022

DOI: 10.5812/ijpr-123825 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Iranian Journal of Pharmaceutical Research, 2022. Verfasst von Mojtaba Ansari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: The determination of radioiodine remnant ablation (RRA) dosage in post-operation thyroid residual tissues resection has been largely subject of discussion, yet no concise conclusion is released through systematic review studies. In this study, we conducted a systematic review of comparative experiments to evaluate and compare the efficacy of different prescribed dosages of radioiodine in post-op thyroid residual tissues resection among low, intermediate, and high-risk patients to approve the common method. Using automated searches, studies were collected from PubMed, Google Scholar, Elsevier, Scopus, and UpToDate, all until April 2021. Alongside the aforementioned sources, comparative experiments were added in for further investigation. Overall, 4000 patients with papillary thyroid cancer, differentiated thyroid carcinoma (DTC), metastasized and non-metastasized thyroid cancer took part in twenty-one trials are assessed. We discovered no significant difference in successful thyroid residual tissues excision between low-activity and high-activity radioiodine treatment in people with low and intermediate risk. In these individuals, there was no significant difference between the high therapeutic dose of 3700 MBq and the lesser dose of 1850 MBq for RRA. However, high-dose treatment usually yielded superior results. Low activity RRA causes fewer adverse effects in metastasis-free patients than high-activity 3.7 GBq. There was no significant therapeutic difference regarding treatment efficacy in patients with low and moderate risks. However, in patients with high-risk status, applying a high-dose regimen of RRA produced a significantly better response.

Schlagwörter

Stichwörter der Autor:innen

DosageRadioiodineSide EffectThyroidTreatment

Autor:innen und Institutionen

  • Faculty of Medicine, Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mojtaba Ansari, Mostafa Rezaei Tavirani

Zitieren

APA

Ansari, M., & Rezaei Tavirani, M. (2022). Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review. Iranian Journal of Pharmaceutical Research. https://doi.org/10.5812/ijpr-123825

Vancouver

Ansari M, Rezaei Tavirani M. Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review. Iranian Journal of Pharmaceutical Research. 2022. doi:10.5812/ijpr-123825

BibTeX
@article{Ansari2022,
  author = {Ansari, Mojtaba and Rezaei Tavirani, Mostafa},
  title = {Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2022},
  doi = {10.5812/ijpr-123825}
}
Kostenlos starten →